BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21750409)

  • 1. From MALT lymphoma to the CBM signalosome: three decades of discovery.
    Rosebeck S; Rehman AO; Lucas PC; McAllister-Lucas LM
    Cell Cycle; 2011 Aug; 10(15):2485-96. PubMed ID: 21750409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.
    Lucas PC; Yonezumi M; Inohara N; McAllister-Lucas LM; Abazeed ME; Chen FF; Yamaoka S; Seto M; Nunez G
    J Biol Chem; 2001 Jun; 276(22):19012-9. PubMed ID: 11262391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
    Juilland M; Thome M
    Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome.
    Delekta PC; Apel IJ; Gu S; Siu K; Hattori Y; McAllister-Lucas LM; Lucas PC
    J Biol Chem; 2010 Dec; 285(53):41432-42. PubMed ID: 21041303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis.
    McAllister-Lucas LM; Jin X; Gu S; Siu K; McDonnell S; Ruland J; Delekta PC; Van Beek M; Lucas PC
    J Biol Chem; 2010 Aug; 285(34):25880-4. PubMed ID: 20605784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.
    Noels H; van Loo G; Hagens S; Broeckx V; Beyaert R; Marynen P; Baens M
    J Biol Chem; 2007 Apr; 282(14):10180-9. PubMed ID: 17287209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation.
    Palkowitsch L; Marienfeld U; Brunner C; Eitelhuber A; Krappmann D; Marienfeld RB
    J Biol Chem; 2011 Mar; 286(9):7522-34. PubMed ID: 21199863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly.
    Qiao Q; Yang C; Zheng C; Fontán L; David L; Yu X; Bracken C; Rosen M; Melnick A; Egelman EH; Wu H
    Mol Cell; 2013 Sep; 51(6):766-79. PubMed ID: 24074955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis and histologic and clinical features of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue type.
    Kuper-Hommel MJ; van Krieken JH
    Leuk Lymphoma; 2012 Jun; 53(6):1032-45. PubMed ID: 21988643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
    Borovecki A; Korac P; Ventura RA; Perisa MM; Banham AH; Dominis M
    Pathol Int; 2007 Jan; 57(1):47-51. PubMed ID: 17199743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C-δ negatively regulates T cell receptor-induced NF-κB activation by inhibiting the assembly of CARMA1 signalosome.
    Liu Y; Song R; Gao Y; Li Y; Wang S; Liu HY; Wang Y; Hu YH; Shu HB
    J Biol Chem; 2012 Jun; 287(24):20081-7. PubMed ID: 22528498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity.
    Pérez de Diego R; Sánchez-Ramón S; López-Collazo E; Martínez-Barricarte R; Cubillos-Zapata C; Ferreira Cerdán A; Casanova JL; Puel A
    J Allergy Clin Immunol; 2015 Nov; 136(5):1139-49. PubMed ID: 26277595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.
    Turvey SE; Durandy A; Fischer A; Fung SY; Geha RS; Gewies A; Giese T; Greil J; Keller B; McKinnon ML; Neven B; Rozmus J; Ruland J; Snow AL; Stepensky P; Warnatz K
    J Allergy Clin Immunol; 2014 Aug; 134(2):276-84. PubMed ID: 25087226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCR-induced NF-kappaB activation: a crucial role for Carma1, Bcl10 and MALT1.
    Thome M; Tschopp J
    Trends Immunol; 2003 Aug; 24(8):419-24. PubMed ID: 12909454
    [No Abstract]   [Full Text] [Related]  

  • 15. The CBM signalosome: potential therapeutic target for aggressive lymphoma?
    Yang C; David L; Qiao Q; Damko E; Wu H
    Cytokine Growth Factor Rev; 2014 Apr; 25(2):175-83. PubMed ID: 24411492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex.
    Rehman AO; Wang CY
    Int J Oral Sci; 2009 Sep; 1(3):105-18. PubMed ID: 20695076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.
    Remstein ED; Dogan A; Einerson RR; Paternoster SF; Fink SR; Law M; Dewald GW; Kurtin PJ
    Am J Surg Pathol; 2006 Dec; 30(12):1546-53. PubMed ID: 17122510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-κB signaling upon T cell activation.
    Schimmack G; Eitelhuber AC; Vincendeau M; Demski K; Shinohara H; Kurosaki T; Krappmann D
    Cell Commun Signal; 2014 Jul; 12():49. PubMed ID: 25245034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COP9 signalosome controls the Carma1-Bcl10-Malt1 complex upon T-cell stimulation.
    Welteke V; Eitelhuber A; Düwel M; Schweitzer K; Naumann M; Krappmann D
    EMBO Rep; 2009 Jun; 10(6):642-8. PubMed ID: 19444310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ancient Origin of the CARD-Coiled Coil/Bcl10/MALT1-Like Paracaspase Signaling Complex Indicates Unknown Critical Functions.
    Staal J; Driege Y; Haegman M; Borghi A; Hulpiau P; Lievens L; Gul IS; Sundararaman S; Gonçalves A; Dhondt I; Pinzón JH; Braeckman BP; Technau U; Saeys Y; van Roy F; Beyaert R
    Front Immunol; 2018; 9():1136. PubMed ID: 29881386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.